Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10204053rdf:typepubmed:Citationlld:pubmed
pubmed-article:10204053lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C0014257lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C0348013lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C0596577lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C0033522lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:10204053lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:10204053pubmed:issue4lld:pubmed
pubmed-article:10204053pubmed:dateCreated1999-4-26lld:pubmed
pubmed-article:10204053pubmed:abstractTextEndothelial activation is important in the pathogenesis of skin changes due to chronic venous disease (CVD). Purified micronised flavonoid fraction has been used for symptomatic treatment of CVD for a considerable period of time. The exact mode of action of these compounds remains unknown.lld:pubmed
pubmed-article:10204053pubmed:languageenglld:pubmed
pubmed-article:10204053pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10204053pubmed:citationSubsetIMlld:pubmed
pubmed-article:10204053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10204053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10204053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10204053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10204053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10204053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10204053pubmed:statusMEDLINElld:pubmed
pubmed-article:10204053pubmed:monthAprlld:pubmed
pubmed-article:10204053pubmed:issn1078-5884lld:pubmed
pubmed-article:10204053pubmed:authorpubmed-author:PorterJJlld:pubmed
pubmed-article:10204053pubmed:authorpubmed-author:ScurrJ HJHlld:pubmed
pubmed-article:10204053pubmed:authorpubmed-author:Coleridge-Smi...lld:pubmed
pubmed-article:10204053pubmed:authorpubmed-author:ShoabS SSSlld:pubmed
pubmed-article:10204053pubmed:issnTypePrintlld:pubmed
pubmed-article:10204053pubmed:volume17lld:pubmed
pubmed-article:10204053pubmed:ownerNLMlld:pubmed
pubmed-article:10204053pubmed:authorsCompleteYlld:pubmed
pubmed-article:10204053pubmed:pagination313-8lld:pubmed
pubmed-article:10204053pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:meshHeadingpubmed-meshheading:10204053...lld:pubmed
pubmed-article:10204053pubmed:year1999lld:pubmed
pubmed-article:10204053pubmed:articleTitleEndothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease--a prospective study.lld:pubmed
pubmed-article:10204053pubmed:affiliationDepartment of Surgery, University College London Medical School, U.K.lld:pubmed
pubmed-article:10204053pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10204053lld:pubmed